Skip to content

Scientific Technology News

About STN
Contact Us

Top-10
Instrument Industry Deals
Product Launches

Merck KGaA, Darmstadt, Germany: Driving Innovation in Cancer Care at ESMO 2017 With New Data in Hard-to-Treat Cancers

August 31, 2017October 21, 2019 by /

Share This.....

Share on linkedin

Share on twitter

Share on facebook

Share on google

Related News:

Roche introduces cobas infinity edge, a new open…
Roche introduces cobas infinity edge, a new open…
Driving New Discoveries With Lattice Light Sheet…
CHMP recommends EU approval of Ronapreve to treat…
Ronapreve approved by European Commission to treat…
CHMP recommends EU approval of Actemra/RoActemra to…

Category: Lab Top-10, Product Launch Tag: Merck KGaA

Post navigation

Previous PostFirst FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific's CTS Dynabeads Technology

Next PostDevelopment of New SUREengine FAST Technology for Significant Reduction in Exposure Dose in Endoscopic Examination of Bile and Pancreatic Ducts

Get market data and industry analysis here. Request a complimentary copy.

Related News

Roche introduces cobas infinity edge, a new open… January 11, 2022
Roche introduces cobas infinity edge, a new open… January 11, 2022
Driving New Discoveries With Lattice Light Sheet… February 21, 2022
CHMP recommends EU approval of Ronapreve to treat… November 11, 2021
Ronapreve approved by European Commission to treat… November 12, 2021
CHMP recommends EU approval of Actemra/RoActemra to… December 6, 2021
Actemra/RoActemra approved by the European… December 7, 2021
FDA approves Roche’s Vabysmo, the first bispecific… January 31, 2022
FDA approves Roche’s Vabysmo, the first bispecific… January 31, 2022
Roche announces U.S. FDA approval of Xofluza to… August 12, 2022

© 2024 Scientific Technology News